FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605462280> ?p ?o ?g. }

• W2605462280 endingPage "5509" @default.
• W2605462280 startingPage "5503" @default.
• W2605462280 abstract "Patterns of microRNA expression appear to delineate the process of spontaneous neoplastic development-transformation (SPNDT) occurring in the African green monkey kidney (AGMK) VERO cell line (Teferedegne et al., 2010). Analysis of microarray data identified 6 microRNAs whose high-level of expression peaked when the World Health Organization 10-87 VERO cells became tumorigenic at passage (p) 190. Six miRNAs were identified as potential biomarkers for the expression of the VERO-cell tumorigenic phenotype (Teferedegne et al., 2014). However, the question remained whether these miRNA biomarkers are specific for VERO cells or can be generalizable to other cells originating from African green monkey kidneys. To examine miRNA expression patterns in AGMK cells at lower passage levels and to re-examine the identified miRNAs as biomarkers associated with tumorigenic phenotype of VERO cells in another independently-derived line, we established a new line of African green monkey kidney cells (AGMK1-9T7) by serially passaging kidney cells from another AGM. The AGMK1-9T7 cells became tumorigenic in nude mice at p40. Evaluation of miRNA expression at intervals from p1 to p40 revealed similarities between the evolution of miRNA expression during SPNDT in the AGMK1-9T7 cells and the 10-87 VERO cells. Four of the 6 potential biomarker miRNAs (miR-376a, miR-654-3p, miR-543, miR-134) in our earlier reports were detected by microarray in the AGMK1-9T7 cells; RT-qPCR analysis detected all 6 miRNAs. All 6 of these miRNAs have been associated with human tumors. Detection of the same miRNAs associated with the tumorigenic p40 AGMK1-9T7 cells and tumorigenic 10-87 VERO cells confirmed our proposal that these miRNA represent biomarkers for the tumor-forming ability of AGMK/VERO cells. The similarities of expression of miRNAs in different AGMK cell lines that were established 50years apart suggest that the process of SPNDT in these non-human primate cells in tissue culture is based upon similar genetic and epigenetic mechanisms." @default.
• W2605462280 created "2017-04-28" @default.
• W2605462280 creator A5010388098 @default.
• W2605462280 creator A5011288755 @default.
• W2605462280 creator A5017520285 @default.
• W2605462280 creator A5028167077 @default.
• W2605462280 creator A5045571152 @default.
• W2605462280 creator A5064332538 @default.
• W2605462280 creator A5066972504 @default.
• W2605462280 date "2017-10-01" @default.
• W2605462280 modified "2023-09-27" @default.
• W2605462280 title "Assessment of potential miRNA biomarkers of VERO-cell tumorigenicity in a new line (AGMK1-9T7) of African green monkey kidney cells" @default.
• W2605462280 cites W1499990855 @default.
• W2605462280 cites W1873506300 @default.
• W2605462280 cites W1973331161 @default.
• W2605462280 cites W1973876456 @default.
• W2605462280 cites W1977613047 @default.
• W2605462280 cites W1992190228 @default.
• W2605462280 cites W1999307118 @default.
• W2605462280 cites W2005065784 @default.
• W2605462280 cites W2005947759 @default.
• W2605462280 cites W2006650984 @default.
• W2605462280 cites W2012511861 @default.
• W2605462280 cites W2020833650 @default.
• W2605462280 cites W2029463176 @default.
• W2605462280 cites W2036294809 @default.
• W2605462280 cites W2060372252 @default.
• W2605462280 cites W2078057245 @default.
• W2605462280 cites W2079701593 @default.
• W2605462280 cites W2089783158 @default.
• W2605462280 cites W2092166712 @default.
• W2605462280 cites W2095435908 @default.
• W2605462280 cites W2095734937 @default.
• W2605462280 cites W2128259013 @default.
• W2605462280 cites W2139443896 @default.
• W2605462280 cites W2148929244 @default.
• W2605462280 cites W2149146453 @default.
• W2605462280 cites W2153521949 @default.
• W2605462280 cites W2169413646 @default.
• W2605462280 cites W2169932230 @default.
• W2605462280 cites W2288753073 @default.
• W2605462280 cites W761743459 @default.
• W2605462280 doi "https://doi.org/10.1016/j.vaccine.2017.04.004" @default.
• W2605462280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28434690" @default.
• W2605462280 hasPublicationYear "2017" @default.
• W2605462280 type Work @default.
• W2605462280 sameAs 2605462280 @default.
• W2605462280 citedByCount "3" @default.
• W2605462280 countsByYear W26054622802020 @default.
• W2605462280 countsByYear W26054622802022 @default.
• W2605462280 crossrefType "journal-article" @default.
• W2605462280 hasAuthorship W2605462280A5010388098 @default.
• W2605462280 hasAuthorship W2605462280A5011288755 @default.
• W2605462280 hasAuthorship W2605462280A5017520285 @default.
• W2605462280 hasAuthorship W2605462280A5028167077 @default.
• W2605462280 hasAuthorship W2605462280A5045571152 @default.
• W2605462280 hasAuthorship W2605462280A5064332538 @default.
• W2605462280 hasAuthorship W2605462280A5066972504 @default.
• W2605462280 hasConcept C104317684 @default.
• W2605462280 hasConcept C127716648 @default.
• W2605462280 hasConcept C145059251 @default.
• W2605462280 hasConcept C150194340 @default.
• W2605462280 hasConcept C153911025 @default.
• W2605462280 hasConcept C159047783 @default.
• W2605462280 hasConcept C174510640 @default.
• W2605462280 hasConcept C186836561 @default.
• W2605462280 hasConcept C2780091579 @default.
• W2605462280 hasConcept C2910145492 @default.
• W2605462280 hasConcept C502942594 @default.
• W2605462280 hasConcept C54009773 @default.
• W2605462280 hasConcept C54355233 @default.
• W2605462280 hasConcept C81885089 @default.
• W2605462280 hasConcept C8415881 @default.
• W2605462280 hasConcept C86803240 @default.
• W2605462280 hasConcept C89138240 @default.
• W2605462280 hasConceptScore W2605462280C104317684 @default.
• W2605462280 hasConceptScore W2605462280C127716648 @default.
• W2605462280 hasConceptScore W2605462280C145059251 @default.
• W2605462280 hasConceptScore W2605462280C150194340 @default.
• W2605462280 hasConceptScore W2605462280C153911025 @default.
• W2605462280 hasConceptScore W2605462280C159047783 @default.
• W2605462280 hasConceptScore W2605462280C174510640 @default.
• W2605462280 hasConceptScore W2605462280C186836561 @default.
• W2605462280 hasConceptScore W2605462280C2780091579 @default.
• W2605462280 hasConceptScore W2605462280C2910145492 @default.
• W2605462280 hasConceptScore W2605462280C502942594 @default.
• W2605462280 hasConceptScore W2605462280C54009773 @default.
• W2605462280 hasConceptScore W2605462280C54355233 @default.
• W2605462280 hasConceptScore W2605462280C81885089 @default.
• W2605462280 hasConceptScore W2605462280C8415881 @default.
• W2605462280 hasConceptScore W2605462280C86803240 @default.
• W2605462280 hasConceptScore W2605462280C89138240 @default.
• W2605462280 hasIssue "41" @default.
• W2605462280 hasLocation W26054622801 @default.
• W2605462280 hasLocation W26054622802 @default.
• W2605462280 hasOpenAccess W2605462280 @default.
• W2605462280 hasPrimaryLocation W26054622801 @default.
• W2605462280 hasRelatedWork W1731478028 @default.

• next